Literature DB >> 6155346

Soluble group- and type-specific antigens from type III group B Streptococcus.

R B Carey, T K Eisenstein, G D Shockman, T F Greber, R M Swenson.   

Abstract

Two soluble polysaccharide antigens of a type III group B Streptoccus were isolated from the culture medium after growth of strain M732 in a chemically defined broth supplemented with acid-hydrolyzed casein. The type- and group- specific antigens were isolated from the culture supernatant by anion-exchange chromatography with diethylaminoethyl-Sephacel. Two carbohydrate-containing peaks, which had serological reactivity with group B or type III antiserum, respectively, were eluted with a linear NaCl gradient and further purified by gel filtration. The type III polysaccharide was found to contain glucose, galactose, glucosamine, and sialic acid, whereas the group B polysaccharide contained galactose, glucosamine, and rhamnose. For the type III polysaccharide, sialic acid was shown to be the major immunodeterminant, and for the group B polysaccharide, rhamnose was the immunodominant sugar. Both the type III and group B polysaccharides were obtained in high yields without employing harsh physical or chemical treatment and both were immunologically distinct. By immunoelectrophoresis or counterimmunoelectrophoresis, type III antigen failed to react with group-specific antiserum and the group B antigen failed to react with type III antiserum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155346      PMCID: PMC550912          DOI: 10.1128/iai.28.1.195-203.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Editorial: Group B streptococci: a serious threat to the neonate.

Authors:  M Yow
Journal:  JAMA       Date:  1974-11-25       Impact factor: 56.272

2.  Group B streptococcal infections in infants. The importance of the various serotypes.

Authors:  C J Baker; F F Barrett
Journal:  JAMA       Date:  1974-11-25       Impact factor: 56.272

3.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

4.  The isolation and some physiochemical and biologic properties of the type 3 antigen of group B streptococci.

Authors:  H Russell; N L Norcross
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

5.  Type-specific polysaccharide antigens of group B streptococci.

Authors:  R C Lancefield; E H Freimer
Journal:  J Hyg (Lond)       Date:  1966-06

6.  Studies on the group F antigen of lactobacilli: antigenicity and serological specificity of teichoic acid preparations.

Authors:  K W Knox; M J Hewett; A J Wicken
Journal:  J Gen Microbiol       Date:  1970-03

7.  Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis).

Authors:  H W Wilkinson; R R Facklam; E C Wortham
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

8.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

9.  An immunological relationship between the group. A streptococcus and mammalian muscle.

Authors:  J B Zabriskie; E H Freimer
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  Type-specific polysaccharide antigens of group B streptococci. II. The chemical basis for serological specificity of the type II HCl antigen.

Authors:  E H Freimer
Journal:  J Exp Med       Date:  1967-03-01       Impact factor: 14.307

View more
  36 in total

1.  Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.

Authors:  M Cuzzola; G Mancuso; C Beninati; C Biondo; C von Hunolstein; G Orefici; T Espevik; T H Flo; G Teti
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Soluble antigens from group B streptococci induce cytokine production in human blood cultures.

Authors:  C von Hunolstein; A Totolian; G Alfarone; G Mancuso; V Cusumano; G Teti; G Orefici
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.

Authors:  D O Chaffin; L M Mentele; C E Rubens
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

4.  Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.

Authors:  G C Palacios; E K Eskew; F Solorzano; S J Mattingly
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

5.  Molecular species of R-protein antigens produced by clinical isolates of group B streptococci.

Authors:  A E Flores; P Ferrieri
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  Absence of significant cellulase activity in microbial flora of the female genital tract.

Authors:  S M Garland; Y C Tsai; M I Kendrick; E H Kass
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

7.  Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid.

Authors:  G Teti; F Tomasello; M S Chiofalo; G Orefici; P Mastroeni
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

8.  Immunoglobulin G and M composition of naturally occurring antibody to type III group B streptococci.

Authors:  B F Anthony; N F Concepcion; C A Wass; D C Heiner
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

9.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

10.  Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.

Authors:  R Bhushan; B F Anthony; C E Frasch
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.